30.07.2010 • NewsCelaneseQ2 results

Celanese Posts Q2 Profit Surge, Boosts 2010 Forecast

Celanese Corp said on Thursday that second-quarter profit rose 50 percent as the improving economy continued to increase demand for its products, and the chemical maker raised its full-year outlook.
Net income rose to $160 million, or $1.01 per share, from $107 million, or 69 cents per share, a year earlier.
Excluding one-time items, the company posted profit of $1.12 per share.

Revenue at the Dallas-based company rose 22 percent to $1.52 billion. Analysts expected $1.46 billion.

Celanese boosted its 2010 adjusted earnings outlook to $1.40 per share above 2009 earnings, or $3.11. It had previously forecast annual profit would be $1.25 above last year's. Analysts expect $3.06.

During the quarter, the company had said its increasingly diverse product line would help increase 2010 earnings.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.